Sigma 1 Receptor Chaperone: Pharmacology and Therapeutic Perspectives
- 4 May 2012
- book chapter
- Published by Wiley
Abstract
No abstract availableKeywords
This publication has 276 references indexed in Scilit:
- Sigma Receptor Agonists: Receptor Binding and Effects on Mesolimbic Dopamine Neurotransmission Assessed by MicrodialysisBiological Psychiatry, 2010
- Demonstration of a Direct Interaction between σ-1 Receptors and Acid-Sensing Ion ChannelsBiophysical Journal, 2010
- Cholesterol at the Endoplasmic Reticulum: Roles of the Sigma-1 Receptor Chaperone and Implications thereof in Human DiseasesPublished by Springer Nature ,2010
- Sigma receptor ligand 4-phenyl-1-(4-phenylbutyl)-piperidine modulates neuronal nitric oxide synthase/postsynaptic density-95 coupling mechanisms and protects against neonatal ischemic degeneration of striatal neuronsExperimental Neurology, 2009
- Selective reduction of alcohol drinking in Sardinian alcohol-preferring rats by a sigma-1 receptor antagonistPsychopharmacology, 2009
- Antagonism by haloperidol and its metabolites of mechanical hypersensitivity induced by intraplantar capsaicin in mice: role of sigma-1 receptorsPsychopharmacology, 2009
- The sigma1 receptor interacts with N-alkyl amines and endogenous sphingolipidsEuropean Journal of Pharmacology, 2009
- Attenuation of methamphetamine-induced effects through the antagonism of sigma (σ) receptors: Evidence from in vivo and in vitro studiesEuropean Neuropsychopharmacology, 2008
- Interactions between 3,4-methylenedioxymethamphetamine and σ1 receptorsEuropean Journal of Pharmacology, 2006
- BMY-14802 reverses the reduction of striatal dopamine release induced by (+)-3-[3-hydroxyphenyl]-N-(1-propyl)piperidineJournal of Neural Transmission, 1992